Intestinal Research

Live-attenuated vaccination in patients with inflammatory bowel disease while continuing or after elective switch to vedolizumab: Hisashi Shiga, Hiroshi Nagai, Yusuke Shimoyama, Takeo Naito, Rintaro Moroi, Yoichi Kakuta, Yoshitaka Kinouchi, Atsushi Masamune; Received December 27, 2023 Accepted February 19, 2024; DOI: https://doi.org/10.5217/ir.2023.00203 [Epub ahead of print]; Full text PubReader ePub PDF

Diagnostic strategy of irritable bowel syndrome: a low- and middle-income country perspective: Amal Arifi Hidayat, Langgeng Agung Waskito, Titong Sugihartono, Hafeza Aftab, Yudith Annisa Ayu Rezkitha, Ratha-korn Vilaichone, Muhammad Miftahussurur; Received December 20, 2023 Accepted February 15, 2024; DOI: https://doi.org/10.5217/ir.2023.00199 [Epub ahead of print]; Full text PubReader ePub PDF

Effects of COVID-19 vaccines on patient-reported outcomes in patients with inflammatory bowel disease: a multicenter survey study in Korea: Jung Hyun Ji, Seung Hwan Shin, Yong Eun Park, Jihye Park, Jae Jun Park, Jae Hee Cheon, Tae Il Kim, Sang-Bum Kang, Sang Hyoung Park, Soo Jung Park, IBD Research Group of the Korean Association for the Study of Intestinal Diseases (KASID); Received July 3, 2023 Accepted January 7, 2024; DOI: https://doi.org/10.5217/ir.2023.00077 [Epub ahead of print]; Full text PubReader ePub PDF

The evolving understanding of histology as an endpoint in ulcerative colitis: Shintaro Akiyama, Yusuke Miyatani, David T. Rubin; Received September 13, 2023 Accepted January 24, 2023; DOI: https://doi.org/10.5217/ir.2023.00120 [Epub ahead of print]; Full text PubReader ePub PDF

Association between nonalcoholic fatty liver disease and incidence of inflammatory bowel disease: a nationwide population‑based cohort study: Ying-Hsiang Wang, Chi-Hsiang Chung, Tien-Yu Huang, Chao-Feng Chang, Chi-Wei Yang, Wu-Chien Chien, Yi-Chiao Cheng; Received July 4, 2023 Accepted December 22, 2023; DOI: https://doi.org/10.5217/ir.2023.00078 [Epub ahead of print]; Full text PubReader ePub PDF Supplementary Material

Ustekinumab for anti-tumor necrosis factor refractory pediatric ulcerative colitis: a promising approach towards endoscopic healing: Rahiya Rehman, Muhammad Safwan Riaz, Dyadin Esharif, Phinnara Has, Michael Herzlinger, Jason Shapiro, Shova Subedi; Received August 1, 2023 Accepted December 6, 2023; DOI: https://doi.org/10.5217/ir.2023.00091 [Epub ahead of print]; Full text PubReader ePub PDF

Association between oral corticosteroid starting dose and the incidence of pneumonia in Japanese patients with ulcerative colitis: a nation-wide claims database study: Katsuyoshi Matsuoka, Tomoyuki Inoue, Hiroaki Tsuchiya, Katsumasa Nagano, Toshiyuki Iwahori; Received June 21, 2023 Accepted November 6, 2023; DOI: https://doi.org/10.5217/ir.2023.00071 [Epub ahead of print]; Full text PubReader ePub PDF Supplementary Material

Helminths in alternative therapeutics of inflammatory bowel disease: Himani Pandey, Daryl W. T. Tang, Sunny H. Wong, Devi Lal; Received May 25, 2023 Accepted November 1, 2023; DOI: https://doi.org/10.5217/ir.2023.00059 [Epub ahead of print]; Full text PubReader ePub PDF

Risk of malignancies and chemopreventive effect of statin, metformin, and aspirin in Korean patients with ulcerative colitis: a nationwide population-based study: Eun Hye Oh, Ye-Jee Kim, Minju Kim, Seung Ha Park, Tae Oh Kim, Sang Hyoung Park; Received June 3, 2023 Accepted September 14, 2023; DOI: https://doi.org/10.5217/ir.2023.00062 [Epub ahead of print]; Full text PubReader ePub PDF Supplementary Material

Ahead-of Print